King's College London is recruiting stroke survivors to share their views on frailty and risk prediction in stroke care. Findings will help improve how this information is explained and used in discussions about care and treatment.
Integrating frailty, chronic conditions and patient characteristics to inform stroke care
King's College London
Open to: People aged 18 or over who had their first stroke more than three months ago and have experience with healthcare services in the UK.
Deadline: 30 September 2026.
Apply: If you are interested in taking part in the study, please contact Dr Sophie Rowland-Coomber at sophie.rowland@kcl.ac.uk. We look forward to hearing from you.
Research participation requests are sent to the Stroke Association from external research institutions (e.g. universities and hospitals).
We conduct checks on these before promoting but are not involved in their running. This means we cannot comment on trials and have no affiliation with them.
What is the opportunity about?
Researchers are looking into how 'frailty' affects stroke recovery as part of a larger study. Frailty refers to being more vulnerable to health problems due to accumulated health difficulties over time.
For this project, researchers want to speak with stroke survivors and carers to understand their views on using frailty information and risk prediction tools in stroke care. They are interested in how these tools should be explained to patients so they understand their health risks, and how healthcare professionals can best use this information to support discussions about care and treatment.
What will it involve?
If you decide to take part, you will be invited to a one-to-one conversation with a researcher lasting around 45 to 60 minutes. The interview will explore your experiences of stroke care, your thoughts on using information about frailty and health risks in stroke care, and how this information could be best communicated to stroke survivors and families.
You can choose to take part online.
Who can take part?
You may be able to take part if you are a stroke survivor aged 18 or over, can give informed consent, have experience of healthcare services in the UK, live in England, Scotland or Wales, and are either:
- A stroke survivor whose first stroke occurred at least three months ago.
- A carer of someone who has had a stroke.
What will you get from taking part?
You may not benefit directly from taking part. However, your feedback will help researchers develop guidance on how frailty information and risk prediction tools can be used and discussed in stroke care.
How can I take part?
If you would like to take part or find out more, please contact Dr Sophie Rowland-Coomber at sophie.rowland@kcl.ac.uk.
They will be happy to answer your questions and explain the next steps.
Information on taking part in research
Research participation helps research teams to test new ideas and approaches by sharing information or trying new approaches in clinical trials.
Taking part in clinical trials can support research to:
- Stop strokes from happening.
- Treat strokes.
- Support stroke survivors and their families to rebuild their lives.
By taking part in research, you can help us to learn more about stroke and make a difference to the lives of future stroke survivors.
Find out how our research has made a difference to people affected by stroke.
We have produced the Clinical Trials and Stroke booklet to explain more about clinical trials and answer questions you might have about taking part. The booklet was produced with the NIHR Clinical Research Network.
Other blogs in this category
- Research and innovation
Research participants needed – e-OPTIMISM study
The University of Nottingham is recruiting people affected by…
- Research and innovation
Research participants needed – aspirin or clopidogrel for people who survive stroke due to bleeding in the brain
Researchers from the University of Edinburgh would like to…
- Research and innovation
World's largest clinical trial to address spatial inattention after stroke
The Stroke Association is supporting SIGHT, a clinical trial…